BforeAI Secures Series B Funding to Preempt Malicious Attacks Through PreCrime™ AI

BforeAI announced an oversubscribed $10M Series B led by Titanium Ventures to accelerate expansion of its PreCrime predictive attack intelligence platform into utilities, pharmaceutical, and healthcare sectors; the release highlights product claims (predictive protection up to 18 days in advance, 0.05% false positive rate), a PreCrime Guarantee, recent recognition by Gartner, and participation by existing investors, but does not describe any security incident or technical threat details.